Co-Diagnostics Inc Welcomes Richard Abbott as New President

An update from Co-Diagnostics Inc (CODX) is now available.

Co-Diagnostics, Inc. has appointed Richard Abbott, a seasoned executive with a strong background in technology and management, as its new President. Abbott brings to the role his experience from leading a subsidiary of Co-Diagnostics and providing consulting services through his partnership at SaltRidge, LLC. His technical expertise is supported by an MBA from Wharton and an MS in Mechanical Engineering from Brigham Young University. The appointment comes with no family ties to the company’s current leadership and follows Abbott’s indirect ownership interest in a subsidiary prior to its acquisition by Co-Diagnostics. He stands to gain additional shares and warrants upon achieving certain milestones, reflecting his vested interest in the company’s success.

For detailed information about CODX stock, go to TipRanks’ Stock Analysis page.